Opportunities to minimise animal use in pharmaceutical regulatory general toxicology: A cross-company review
Susan Sparrow(GlaxoSmithKline (United Kingdom)), Sally Robinson(AstraZeneca (United Kingdom)), Sue Bolam(Covance (United Kingdom)), Chris Bruce(Pfizer (United States)), Andy Danks(Charles River Laboratories (United Kingdom)), David J. Everett(Covance (United Kingdom)), Stephen Fulcher, Rose E. Hill, Helen Palmer, Elspeth W. Scott, Kathryn Chapman(National Centre for the Replacement Refinement and Reduction of Animals in Research)
Cited by 61
Abstract
Related Papers
No related papers found
Powered by citation graph analysis